TABLE 3

Comparison of Baseline Characteristics Between Equivocal Cases That Showed Definitive Result After LNM and Those That Remained Equivocal

CharacteristicAll (n = 36)Definitive (n = 25)Equivocal (n = 11)P
Median age (y)40 (range, 19–70)40 (range, 19–70)35 (range, 20–69)0.52
Sex
 Male6 (17)5 (20)1 (9.1)0.64
 Female30 (83)20 (80)10 (91)
Race
 White29 (81)21 (84)8 (73)0.096
 Black3 (8.3)3 (12)0 (0.0)
 Hispanic3 (8.3)1 (4.0)2 (18)
 Mixed1 (2.8)0 (0.0)1 (9.1)
Body mass index
 ≤196 (17)5 (20)1 (9.1)0.70
 20–2411 (31)6 (24)5 (45.5)
 25–298 (22)6 (24)2 (18.2)
 ≥3011 (31)8 (32)3 (27.3)
Symptoms
 Nausea32 (89)22 (88)10 (91)1.00
 Vomiting24 (67)17 (68)7 (64)1.00
 Abdominal pain13 (36)9 (36)4 (36)1.00
 Early satiety12 (33)11 (44)1 (9.1)0.059
 Weight loss8 (22)4 (16)4 (36)0.21
 Bloating/distention8 (22)5 (20)3 (27)0.68
 Diarrhea9 (25)6 (24)3 (27)1.00
Constipation3 (8.3)2 (8.0)1 (9.1)1.00
 Decreased appetite/anorexia4 (11)3 (12)1 (9.1)1.00
 Belching1 (2.8)1 (4.0)0 (0.0)1.00
Diagnosis
Gastroparesis23 (64)13 (52)10 (91)0.031
 Cyclic vomiting syndrome2 (5.6)2 (8.0)0 (0.0)1.00
 IBS3 (8.3)0 (0.0)3 (27)0.023
 SIBO5 (14)3 (12)2 (18)0.63
 Malignancy0 (0.0)0 (0.0)0 (0.0)0.63
 GERD5 (14)5 (20)0 (0.0)0.30
 Dumping syndrome1 (2.8)0 (0.0)1 (9.1)0.31
 Unspecified5 (14)5 (20)0 (0.0)0.30
  • SIBO = small intestinal bacterial overgrowth; GERD = gastroesophageal reflux disease.

  • Except for age, data are numbers followed by percentage in parentheses; n = 36 patients total.